###begin article-title 0
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 40 56 40 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 40 56 <span type="species:ncbi:5478">Candida glabrata</span>
Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence
###end article-title 0
###begin p 1
Current address: Selexis SA, Plan-les-Ouates/Geneva, Switzerland
###end p 1
###begin p 2
Conceived and designed the experiments: SF MS DS. Performed the experiments: SF FI DC BP MS BR CB. Analyzed the data: SF BP MS BR CB DS. Contributed reagents/materials/analysis tools: GF OB. Wrote the paper: SF DS.
###end p 2
###begin p 3
###xml 13 29 13 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 215 221 215 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 271 277 271 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 402 408 402 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 519 527 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 532 539 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 744 750 744 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1057 1063 1057 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1065 1071 1065 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 1077 1083 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 1148 1154 1148 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1208 1213 1208 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 1238 1244 1238 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1251 1254 1251 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1387 1398 1387 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1426 1432 1426 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1595 1601 1595 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1748 1754 1748 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1794 1802 1794 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1803 1810 1803 1810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 13 29 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 1387 1398 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
###xml 1679 1684 <span type="species:ncbi:10090">mouse</span>
CgPdr1p is a Candida glabrata Zn(2)-Cys(6) transcription factor involved in the regulation of the ABC-transporter genes CgCDR1, CgCDR2, and CgSNQ2, which are mediators of azole resistance. Single-point mutations in CgPDR1 are known to increase the expression of at least CgCDR1 and CgCDR2 and thus to contribute to azole resistance of clinical isolates. In this study, we investigated the incidence of CgPDR1 mutations in a large collection of clinical isolates and tested their relevance, not only to azole resistance in vitro and in vivo, but also to virulence. The comparison of CgPDR1 alleles from azole-susceptible and azole-resistant matched isolates enabled the identification of 57 amino acid substitutions, each positioned in distinct CgPDR1 alleles. These substitutions, which could be grouped into three different "hot spots," were gain of function (GOF) mutations since they conferred hyperactivity to CgPdr1p revealed by constitutive high expression of ABC-transporter genes. Interestingly, the major transporters involved in azole resistance (CgCDR1, CgCDR2, and CgSNQ2) were not always coordinately expressed in presence of specific CgPDR1 GOF mutations, thus suggesting that these are rather trans-acting elements (GOF in CgPDR1) than cis-acting elements (promoters) that lead to azole resistance by upregulating specific combinations of ABC-transporter genes. Moreover, C. glabrata isolates complemented with CgPDR1 hyperactive alleles were not only more virulent in mice than those with wild type alleles, but they also gained fitness in the same animal model. The presence of CgPDR1 hyperactive alleles also contributed to fluconazole treatment failure in the mouse model. In conclusion, this study shows for the first time that CgPDR1 mutations are not only responsible for in vitro/in vivo azole resistance but that they can also confer a selective advantage under host conditions.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 108 119 108 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 587 598 587 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 692 698 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 976 982 976 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1097 1108 1097 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 0 16 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 22 27 <span type="species:ncbi:4932">yeast</span>
###xml 56 62 <span type="species:ncbi:9606">humans</span>
###xml 100 106 <span type="species:ncbi:9606">people</span>
###xml 108 119 <span type="species:ncbi:5478">C. glabrata</span>
###xml 277 282 <span type="species:ncbi:4932">yeast</span>
###xml 587 598 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1097 1108 <span type="species:ncbi:5478">C. glabrata</span>
Candida glabrata is a yeast causing several diseases in humans and especially in immuno-compromised people. C. glabrata infections are treated with antifungal agents, however the use of some agents, for example azoles, is associated with the development of resistance. In this yeast species, azole resistance is mediated almost exclusively by ATP Binding Cassette (ABC) multidrug transporters. Their overexpression results in enhanced efflux of azoles and thus generates resistance. Regulation of ABC transporters is therefore of pivotal importance to understanding azole resistance. In C. glabrata, the expression of ABC transporters is mediated by a zinc finger transcription factor called CgPDR1. Gain of function (GOF) mutations in CgPDR1 result in high ABC transporter expression. In this study, we investigated the occurrence of GOF mutations in a large collection of azole-resistant isolates and found a high variety of mutations localized in three distinct domains of CgPDR1. We found that these mutations are not only associated with resistance but also enhanced virulence and fitness of C. glabrata in animal models. Our study provides for the first time evidence that mutations causing antifungal resistance can also provide a selective advantage under host conditions and thus highlights the need of carefully monitoring resistance in this pathogen.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 203 206 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Pappas1">[1]</xref>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Pfaller1">[2]</xref>
###xml 239 250 239 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 429 432 429 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Pfaller2">[3]</xref>
###xml 447 458 447 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 552 555 552 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Bennett1">[4]</xref>
###xml 556 559 556 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Pfaller4">[6]</xref>
###xml 0 16 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 239 250 <span type="species:ncbi:5478">C. glabrata</span>
###xml 447 458 <span type="species:ncbi:5478">C. glabrata</span>
###xml 534 541 <span type="species:ncbi:9606">patient</span>
Candida glabrata has recently emerged as the second most common cause of invasive candidiasis, and there are increasing numbers of reports showing its important role in mucosal or bloodstream infections [1],[2]. Systemic infections due to C. glabrata are characterized by a high mortality rate, and they are difficult to treat due to the intrinsically low susceptibility of this species to azole drugs, especially to fluconazole [3]. In addition, C. glabrata easily develops fluconazole resistance in response to drug exposure during patient treatment [4]-[6].
###end p 7
###begin p 8
###xml 90 95 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERG11</italic>
###xml 216 221 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ERG11</italic>
###xml 406 409 402 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard1">[7]</xref>
###xml 593 604 589 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 671 677 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 703 709 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 725 729 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDH1</italic>
###xml 773 776 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Bennett1">[4]</xref>
###xml 778 781 774 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Miyazaki1">[8]</xref>
###xml 782 786 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky1">[11]</xref>
###xml 830 841 826 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 878 884 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 888 901 884 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1/CgCDR2</italic>
###xml 982 985 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Bennett1">[4]</xref>
###xml 986 989 982 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard2">[9]</xref>
###xml 990 994 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard3">[10]</xref>
###xml 995 999 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Izumikawa1">[12]</xref>
###xml 1000 1004 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanguinetti1">[13]</xref>
###xml 111 116 <span type="species:ncbi:4932">yeast</span>
###xml 593 604 <span type="species:ncbi:5478">C. glabrata</span>
###xml 830 841 <span type="species:ncbi:5478">C. glabrata</span>
Azole antifungals target the cytochrome P-450 lanosterol 14-alpha demethylase, encoded by ERG11. Resistance of yeast clinical isolates to azole antifungal agents can result from either overexpression or mutations in ERG11. Alternatively, the cells can fail to accumulate azole antifungal agents due to enhanced drug efflux, a consequence of transcriptional activation of drug efflux pumps (for review, see [7]). At least two families of multidrug transporters, the ABC (ATP-binding cassette) transporter family and the major facilitator superfamily (MFS), are involved in azole resistance. In C. glabrata, the constitutive upregulated expression of ABC-transporter genes CgCDR1 and, to a lesser extent, CgCDR2 (also known as PDH1) plays a dominant role in azole resistance [4], [8]-[11]. Each of these genes can be upregulated in C. glabrata clinical isolates and disruption of CgCDR1 or CgCDR1/CgCDR2 leads to hypersusceptibility to fluconazole, cycloheximide, and chloramphenicol [4],[9],[10],[12],[13].
###end p 8
###begin p 9
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 115 128 115 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky1">[11]</xref>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 182 188 182 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 357 363 357 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 459 472 459 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 474 480 474 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 626 632 626 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 717 721 717 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 723 729 723 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 807 818 807 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 850 856 850 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 930 936 930 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1007 1011 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 1195 1199 1195 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Thakur1">[16]</xref>
###xml 1379 1383 1379 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Thakur1">[16]</xref>
###xml 115 128 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 459 472 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 807 818 <span type="species:ncbi:5478">C. glabrata</span>
The expression of CgCDR genes is regulated by a single Zn(2)-Cys(6) transcription factor, CgPdr1p, an homologue of S. cerevisiae Pdr1p/Pdr3p [11]. CgPDR1 deletion leads to a loss of CgCDR1 and CgCDR2 regulation and to a sharp increase in azole susceptibility [14]. Due to the presence of PDRE (pleiotropic drug response element) sequences in the CgCDR1 and CgCDR2 promoters, CgPdr1p acts probably by binding to these regulatory elements as Pdr1p and Pdr3p in S. cerevisiae. CgPDR1 contains a PDRE in its promoter suggesting an auto-regulation of its transcription. Consistent with this observation, upregulation of CgCDR1 and CgCDR2 in azole-resistant strains is correlated with an increase of CgPDR1 expression [14],[15]. CgPDR1 is also essential in azole resistance caused by mitochondrial dysfunction in C. glabrata petite mutants. Since enhanced CgPDR1 expression is observed in some petite mutants, it has been proposed that CgPDR1 regulates its own expression in response to mitochondrial dysfunction [15]. CgPdr1p acts as nuclear receptor by directly binding to diverse drugs and xenobiotics, such as azoles, to activate expression of efflux pumps genes resulting in multidrug resistance [16]. The activation domain of CgPdr1p binds directly to the Mediator co-activator subunit CgGal11p in a xenobiotic-dependent manner in order to activate transcription of target genes [16].
###end p 9
###begin p 10
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 193 199 193 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 204 210 204 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 218 222 218 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 341 352 341 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 591 597 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 602 608 602 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 608 612 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 341 352 <span type="species:ncbi:5478">C. glabrata</span>
Two studies have identified three separate amino acid substitutions (W297S, F575L, P927L) in CgPdr1p of azole-resistant strains that are responsible for constitutive high expression of CgCDR1, CgCDR2 and CgPDR1 itself [14],[15]. Recently, another Pdr1p-regulated ABC-transporter gene, CgSNQ2, was shown to participate to azole resistance of C. glabrata clinical isolates [17]. In this study, a fourth CgPdr1p amino substitution, P822L, was identified. Interestingly, the P822L substitution is responsible for the constitutive overexpression of CgSNQ2, but has no effect on the expression of CgCDR1 and CgCDR2[17].
###end p 10
###begin p 11
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 175 181 175 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 228 239 228 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 288 294 288 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 390 398 390 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 438 445 438 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 506 512 506 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 694 700 694 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 702 708 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 713 719 713 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 930 936 930 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1140 1146 1140 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 228 239 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1068 1073 <span type="species:ncbi:10090">mouse</span>
In the present study, we investigated the incidence of CgPDR1 mutations in a large collection of clinical isolates. Because no study has yet addressed whether the presence of CgPDR1 mutations is correlated with fitness costs in C. glabrata, we engineered isogenic strains with individual CgPDR1 mutations and tested their virulence in two different animal models. The strains that acquired in vitro azole resistance were used to test the in vivo response to fluconazole. We observed a high diversity among CgPDR1 alleles and identified 57 distinct single amino acid substitutions, which may confer hyperactivity to CgPdr1p in order to mediate high expression of ABC transporter genes. Although CgCDR1, CgCDR2 and CgSNQ2 are all regulated by CgPdr1p, they are not always coordinately expressed in azole-resistant isolates indicating that ABC transporter genes were differentially regulated depending on the mutation present on the CgPDR1 allele. Finally, the identified amino acid substitutions in CgPdr1p enhanced virulence and led to fluconazole treatment failure in mouse models. Taken together our data demonstrate a high variability in CgPDR1 mutations, which themselves have differentiated effects on target genes including ABC-transporters and probably on yet unidentified virulence factors.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 54 65 54 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 54 65 <span type="species:ncbi:5478">C. glabrata</span>
Isolation and Characterization of CgPDR1 Alleles from C. glabrata Clinical Isolates
###end title 13
###begin p 14
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 70 81 70 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 602 610 590 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s006">Table S1</xref>
###xml 722 728 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 730 736 718 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 740 746 728 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 752 760 740 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 860 869 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s001">Figure S1</xref>
###xml 930 936 918 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1134 1140 1122 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1167 1173 1155 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1521 1529 1509 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s007">Table S2</xref>
###xml 1699 1712 1687 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 1806 1814 1794 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g002">Figure 2</xref>
###xml 2044 2052 2032 2040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s007">Table S2</xref>
###xml 2178 2184 2166 2172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2284 2290 2272 2278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2332 2343 2320 2331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2536 2542 2524 2530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2651 2656 2639 2644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 2664 2670 2652 2658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 70 81 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1699 1712 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 2332 2343 <span type="species:ncbi:5478">C. glabrata</span>
The incidence of CgPDR1 mutations was investigated in a collection of C. glabrata clinical isolates (n = 122) consisting of 30 groups of sequential isolates (n = 66). Each group contained at least one azole-susceptible (MIC fluconazole</=16 microg/ml) and one azole-resistant (MIC fluconazole>/=32 microg/ml) isolates, which were shown to be highly related by genotyping methods (Cg6 and Cg12 repetition probes or MLST) (data not shown). There were 36 azole-resistant isolates among the groups of related isolates. The 56 remaining isolates were unrelated (41 azole-resistant and 15 azole-susceptible, Table S1). In this collection, azole-resistant isolates upregulated at least one of the ABC-transporter genes including CgCDR1, CgCDR2 or CgSNQ2 (see Figure 1 for ABC-transporter genes expression levels measured by real-time RT-PCR in groups of isolates and Figure S1 for CgCdr1p and CgCdr2p levels determined by western blot). CgPDR1 from each isolate was cloned and sequenced. To determine nucleotide polymorphisms, the 122 sequences were aligned and showed 66 non-synonymous nucleotide substitutions among a total of 70 distinct CgPDR1 alleles. By comparison of CgPDR1 alleles from azole-susceptible and azole-resistant isolates, we identified 12 different alleles recovered only from azole-susceptible isolates containing combinations of eight different mutations and 58 different alleles specific for azole-resistant isolates with 58 distinct mutations. These mutations yielded 57 single amino acid substitutions (Table S2) located at 50 locations along the protein and encompassing three distinct protein domains: i) the region similar to the transcriptional inhibitory domain of Pdr1p from S. cerevisiae, ii) the middle homology region (MHR) and iii) a putative transcriptional activation domain (Figure 2). Eleven distinct amino acids substitutions were found repeatedly in azole-resistant resistant isolates (six found twice and five found three times) and several substitutions occurred at the same position in six different cases (Table S2). Overall, CgPdr1p unique substitutions were found in 46 distinct azole-resistant isolates. This suggests that saturation of CgPDR1 mutations in azole-resistant isolates may be still not reached. Indeed, a parallel and independent CgPDR1 sequence analysis of ten azole-resistant C. glabrata isolates still revealed one unknown mutation and two additional distinct mutations on one of the 51 nucleotide positions identified in this study (O. Bader, unpublished). We hypothesized that CgPDR1 mutations may confer enhanced activity (or hyperactivity) to CgPdr1p leading to increased expression of the CgCDR and/or CgSNQ2 genes.
###end p 14
###begin title 15
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 22 28 22 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 34 40 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 44 55 44 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 44 55 <span type="species:ncbi:5478">C. glabrata</span>
Expression of CgCDR1, CgCDR2, and CgSNQ2 in C. glabrata azole-resistant isolates from groups of sequential clinical isolates.
###end title 15
###begin p 16
Quantification was performed by real-time RT-PCR. The values, which are averages of four separated experiments, represent the increase in gene expression relative to the azole-susceptible parental strains (set at 1.00). Error bars show standard deviations.
###end p 16
###begin title 17
Localisation of 65 non-synonymous substitutions in CgPdr1p.
###end title 17
###begin p 18
###xml 35 41 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 520 533 520 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky1">[11]</xref>
###xml 520 533 <span type="species:ncbi:4932">S. cerevisiae</span>
The eight polymorphisms present in CgPDR1 alleles from both azole-susceptible and azole-resistant isolates are indicated by grey bars. The 57 amino acid polymorphisms (from a total of 58 mutations) specific for CgPDR1 alleles from azole-resistant isolates are indicated by black bars. Putative DBD (DNA binding domain) and MHR (middle homology region) were located by Pfam analysis. ID (putative inhibitory domain) and AD (putative transcriptional activation domain) were deduced by similarity with Pdr1p and Pdr3p from S. cerevisiae[11]. The limits of these domains are indicated by amino acids position in CgPdr1p.
###end p 18
###begin p 19
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Bouchara1">[18]</xref>
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s002">Figure S2</xref>
###xml 563 569 563 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 622 628 622 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 285 293 <span type="species:ncbi:9606">patients</span>
Azole resistance was generally correlated with the occurrence of mutations in CgPDR1, except in four azole-resistant isolates (DSY717, DSY2282, DSY2325 and BPY41). Mitochondrial dysfunction is one of the possible mechanism by which azole resistance can occur during azole treatment of patients [18]. Indeed, three isolates (DSY2282, DSY2325 and BPY41) displayed altered mitochondrial respiratory capacity as deduced from their inability to grow on medium containing glycerol as sole carbon source and from their defects in mitochondrial DNA (Figure S2). Although CgCDR1 was upregulated in the remaining isolate DSY717, no CgPDR1 mutation could be detected. We are currently investigating azole resistance in this isolate and these data will be reported elsewhere.
###end p 19
###begin title 20
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
CgPDR1 Expression Levels Have a Moderate Effect on Azole Resistance
###end title 20
###begin p 21
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 222 228 222 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 299 305 299 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 399 406 399 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000268-t001">Table 1</xref>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g003">Figure 3</xref>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 656 662 656 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 705 713 705 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g003">Figure 3</xref>
###xml 753 759 753 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 821 827 821 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1044 1052 1044 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g003">Figure 3</xref>
Single point mutations in CgPDR1 have been shown to increase the expression of both CgCDR genes and CgPDR1, thus contributing to azole resistance of clinical isolates [14],[15]. To evaluate whether the expression level of CgPDR1 is important for the upregulation of CgCDR genes in our isolates, the CgPDR1 mRNA levels of 21 matched pairs of azole-susceptible and azole-resistant isolates (listed in Table 1) were quantified by slot blot analysis and real-time RT-PCR (Figure 3). The comparison between CgPDR1 expression levels from azole-susceptible and azole-resistant matched isolates yielded comparable results as judged by similar relative increase of CgPDR1 expression obtained with the two methods (Figure 3). We concluded from these results that CgPDR1 upregulation was not correlating with azole resistance since CgPDR1 was overexpressed up to two-fold in some resistant isolates (DSY2268, DSY565, DSY756) as compared to their matched azole-susceptible isolate, whereas it was similarly expressed in others (DSY2257, DSY2277, DSY2271) (Figure 3).
###end p 21
###begin title 22
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Expression of CgPDR1 in matched pairs of azole-susceptible (S) and azole-resistant (R) isolates.
###end title 22
###begin p 23
###xml 115 121 115 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 352 358 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 520 540 520 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 637 643 635 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
RNA was isolated from log phase cultures, slot-blotted to membranes and hybridized with the indicated gene probes. CgACT1 served as internal control. Signals obtained in blotted membranes were quantified by counting radioactivity by phosphor imaging. Signals obtained for CgPDR1 were normalized with CgACT1. Expression values represent the increase of CgPDR1 expression in azole-resistant isolates relative to their azole-susceptible parental strains. RNA was also used for real-time quantitative RT-PCR as described in Material and Methods. Values given on the right diagram are means (+/-SEM) of three separate experiments and express CgPDR1 relative expression in resistant isolates as compared to their matched susceptible parents.
###end p 23
###begin title 24
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 49 60 49 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 49 60 <span type="species:ncbi:5478">C. glabrata</span>
Azole susceptibilities and CgPDR1 mutations from C. glabrata clinical isolates.
###end title 24
###begin p 25
MICs to these antifungal agents were determined by broth microdilution method in accordance with the CLSI M27-A2 document (National Committee for Clinical Laboratory Standards, 2002).
###end p 25
###begin p 26
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Numbers correspond to the positions of amino acid changes while numbers in parentheses correspond to the position of changed nucleotides changed in CgPDR1 relative to the ATG start codon.
###end p 26
###begin p 27
FLC: Fluconazole; ITC: itraconazole; KTC: ketoconazole.
###end p 27
###begin p 28
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Kitada1">[19]</xref>
###xml 378 384 378 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 494 500 494 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 581 587 581 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 656 665 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g004">Figure 4A</xref>
###xml 766 782 766 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g004">Figure 4B and 4C</xref>
###xml 847 853 847 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 919 925 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
To determine whether the two-fold increase in CgPDR1 expression observed in some isolates was sufficient to induce high levels of CgCdr1p and CgCdr2p and thus azole resistance, CgPDR1 alleles from an azole-susceptible and an azole-resistant matched isolate (DSY2235 and DSY2234, respectively) were cloned into the CEN-ARS plasmid pCgACU-5 [19] and expressed in a strain lacking CgPDR1. The CgPDR1 alleles from DSY2235 and DSY2234 only differ by the amino acid substitution T588A. Expression of CgPDR1 alleles from the episomal plasmid resulted in a three- to four-fold increase of CgPDR1 mRNA in the revertant strains as compared to the clinical isolates (Figure 4A), but no significant change was observed in CgCdr1p and CgCdr2p levels and in azole susceptibility (Figure 4B and 4C). Similar results were obtained by overexpressing other mutated CgPDR1 alleles (data not shown), indicating that the slight increase in CgPDR1 expression observed in some resistant isolates could not account for azole resistance.
###end p 28
###begin title 29
###xml 10 16 10 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Effect of CgPDR1 expression on azole resistance.
###end title 29
###begin p 30
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 160 166 160 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 251 257 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 518 524 514 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 675 681 671 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 703 709 699 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 787 793 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 880 886 876 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 937 948 933 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1027 1033 1023 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1051 1055 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 1236 1247 1222 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1329 1335 1315 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1349 1353 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 1529 1532 1511 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard2">[9]</xref>
###xml 937 948 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1236 1247 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1446 1452 <span type="species:ncbi:9986">rabbit</span>
(A) Expression of CgPDR1 in a matched pair of azole-susceptible and azole-resistant isolates (DSY2235 and DSY2234), in revertant strains ("rev") overexpressing CgPDR1 alleles from an episomal plasmid in a pdr1Delta mutant derived from DSY562 (SFY53). CgPDR1 alleles present in each strain ("DSY" for clinical strains and "rev" for revertant strains) were named according to their strain number origin. RNA was isolated from log phase cultures, slot-blotted to membranes, and hybridized with the indicated gene probes. CgACT1 served as internal control. Signals obtained in blotted membranes were quantified by counting radioactivity by phosphor imaging. Signals obtained for CgPDR1 were normalized with CgACT1 and substracted from background. Expression values represent the increase of CgPDR1 expression in revertant strains relative to the clinical isolates expressing the same CgPDR1 allele. (B) Fluconazole susceptibility testing of C. glabrata clinical isolates DSY2235 and DSY2234, revertant strains (rev) overexpressing CgPDR1 alleles and of a pdr1Delta mutant (SFY53). Isolates were grown on YPD medium containing the drug at the indicated concentration at 30degreesC for two days. (C) Immunodetection of CgCdr1p and CgCdr2p in C. glabrata clinical isolates DSY2235 and DSY2234, in revertant strains (rev) overexpressing CgPDR1 alleles in a pdr1Delta mutant (SFY53). Proteins extract were separated by SDS-10% PAGE and immunoblotted with rabbit polyclonal anti-CgCdr1p and anti-CgCdr2p antibodies as described previously [9]. MICs to fluconazole were determined by broth microdilution method in accordance with the CLSI M27-A2 document (National Committee for Clinical Laboratory Standards, 2002).
###end p 30
###begin title 31
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
CgPDR1 Mutations Induce Azole Resistance
###end title 31
###begin p 32
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 423 427 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 442 448 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 590 596 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 745 750 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 758 774 754 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g005">Figure 5A and 5B</xref>
###xml 864 868 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 894 900 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 945 951 937 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 953 959 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 964 970 956 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 1073 1082 1065 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g005">Figure 5B</xref>
###xml 1103 1109 1095 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1254 1265 1246 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1314 1323 1306 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g005">Figure 5C</xref>
###xml 1254 1265 <span type="species:ncbi:5478">C. glabrata</span>
The identified CgPDR1 mutations were next investigated for their ability to confer hyperactivity to CgPdr1p by mediating high expression of ABC-transporter genes resulting in azole resistance. For this purpose, CgPDR1 was first inactivated in a pair of azole-susceptible and azole-resistant isolates (DSY562 and DSY565, respectively) and reintroduced at the CgPDR1 genomic locus by homologous recombination in the obtained pdr1Delta strains. CgPDR1 alleles from these two isolates only differ by the amino acid substitution L280F in the putative inhibitory domain of CgPdr1p. Disruption of CgPDR1 in both azole-susceptible and azole-resistant isolates led to a drastic increase of azole susceptibility and to the complete downregulation of both CgCDR genes (Figure 5A and 5B), thus confirming the involvement of CgPdr1p in azole resistance. Each DSY562 and DSY565 pdr1Delta mutant received the CgPDR1 wild type or mutated alleles. Expression of CgCDR1, CgCDR2 and CgSNQ2 in reconstituted strains was restored to similar levels than those of the original clinical isolates (Figure 5B). Expression of the CgPDR1 allele containing the L280F substitution was sufficient to confer CgCdr1p and CgCdr2p constitutive high expression and thus azole resistance in C. glabrata independently on the strain genetic background (Figure 5C).
###end p 32
###begin title 33
###xml 54 65 54 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 54 65 <span type="species:ncbi:5478">C. glabrata</span>
Quantitative analysis of azole resistance in selected C. glabrata isolates.
###end title 33
###begin p 34
###xml 42 53 42 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 301 305 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 326 330 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 351 355 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 398 404 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 434 438 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 447 452 425 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L280F</sup>
###xml 486 492 464 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 545 549 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 575 579 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 588 593 558 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L280F</sup>
###xml 621 627 591 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 629 635 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 641 647 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 651 662 621 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1000 1011 970 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1232 1235 1202 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard2">[9]</xref>
###xml 42 53 <span type="species:ncbi:5478">C. glabrata</span>
###xml 651 662 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1000 1011 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1149 1155 <span type="species:ncbi:9986">rabbit</span>
(A) Fluconazole susceptibility testing of C. glabrata clinical isolates DSY562 and DSY565 and their derivative mutants. Isolates were grown on YPD medium containing the drug at the indicated concentration at 30degreesC for two days. The indicated genotypes correspond to the following strains: DSY562 pdr1Delta: SFY92; DSY565 pdr1Delta: SFY94; DSY562 pdr1Delta+562 (standing for re-introduction of CgPDR1 from DSY562): SFY114; DSY562 pdr1Delta+565L280F (standing for re-introduction of CgPDR1 from DSY565 with L280F substitution): SFY115; DSY565pdr1Delta+562: SFY118; DSY565 pdr1Delta+565L280F: SFY119. (B) Expression of CgCDR1, CgCDR2, and CgSNQ2 in C. glabrata clinical isolates DSY562 and DSY565 and their derivative mutants. Quantification was performed by real-time RT-PCR. The values, which are averages of four separated experiments, represent the increase in gene expression relative to DSY562 (set at 1.00). Error bars show standard deviations. (C) Immunodetection of CgCdr1p and CgCdr2p in C. glabrata clinical isolates DSY562 and DSY565 and their derivative mutants. Proteins extract were separated by SDS-10% PAGE and immunoblotted with rabbit polyclonal anti-CgCdr1p and anti-CgCdr2p antibodies as described previously [9]. MICs to fluconazole were determined by broth microdilution method in accordance with the CLSI M27-A2 document.
###end p 34
###begin p 35
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 60 67 60 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000268-t001">Table 1</xref>
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 460 464 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 518 527 510 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6A</xref>
###xml 586 592 578 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 664 673 656 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6B</xref>
###xml 886 892 878 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 954 960 946 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1072 1078 1064 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1088 1097 1080 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s003">Figure S3</xref>
Selected CgPDR1 alleles from eight other pairs of isolates (Table 1) were reintroduced at the CgPDR1 genomic locus in an azole-susceptible background lacking CgPDR1. CgPDR1 alleles from each pair of isolates only differ by a point mutation leading to a single amino acid substitution in either the inhibitory domain, the MHR or the activation domain of CgPdr1p. These mutations, which were specific for azole-resistant isolates, restored azole resistance in a pdr1Delta mutant (fluconazole MICs from 64-128 microg/ml, Figure 6A). Since only alleles containing these mutations conferred CgCDR1 constitutive high expression (from 4- to 150-fold expression increase, Figure 6B), these mutations could be assigned as GOF mutations. Moreover, single amino acid substitutions in either the inhibitory domain, the MHR or the activation domain could confer drug resistance. Once again, altered CgPDR1 expression could not account for azole resistance, since the CgPDR1 mRNA levels were similar between the clinical strains and the revertant strains expressing their corresponding CgPDR1 alleles (Figure S3).
###end p 35
###begin title 36
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 40 51 40 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 40 51 <span type="species:ncbi:5478">C. glabrata</span>
Reconstitution of CgPDR1 GOF alleles in C. glabrata.
###end title 36
###begin p 37
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 102 108 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 348 352 344 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 372 377 364 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L328F</sup>
###xml 402 407 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R376W</sup>
###xml 435 441 427 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D1082G</sup>
###xml 468 473 460 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T588A</sup>
###xml 499 504 491 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T607S</sup>
###xml 529 535 521 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E1083Q</sup>
###xml 561 566 553 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Y584C</sup>
###xml 592 597 584 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D876Y</sup>
###xml 612 617 604 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P882L</sup>
###xml 645 651 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 653 659 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 665 671 657 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 686 690 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 739 745 727 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
(A) Fluconazole susceptibility testing of DSY562 pdr1Delta mutant strain (SFY93) expressing different CgPDR1 alleles, which were named according to their strain number origin and by indicating the amino acid substitution (in superscript) associated with a specific strain number. The following strains correspond to the indicated genotypes: DSY562 pdr1Delta+486:SFY98; 489L328F: SFY99; 738: SFY100; 739R376W: SFY101; 2253: SFY102; 2254D1082G:SFY103; 2235: SFY104; 2234T588A: SFY105; 701: SFY106; 704T607S: SFY107; 529:SFY108; 530E1083Q: SFY109; 753: SFY110; 754Y584C: SFY111; 726: SFY112; 727D876Y: SFY113; BPY55P882L: SFY116. (B) Expression of CgCDR1, CgCDR2, and CgSNQ2 in the DSY562 pdr1Delta mutant strain (SFY93) expressing different CgPDR1 alleles, named according to their strain number origin. Quantification was performed by real-time RT-PCR. The values, which are averages of four separated experiments, represent the increase in gene expression relative to DSY562 (set at 1.00). Error bars show standard deviations.
###end p 37
###begin title 38
###xml 9 15 9 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Distinct CgPDR1 GOF Mutations Have Differentiated Effects on ABC-Transporter Genes Expression
###end title 38
###begin p 39
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000268-t001">Table 1</xref>
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 325 331 325 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 337 343 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 443 449 443 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 737 745 737 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 775 781 775 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 971 977 971 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1084 1090 1084 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 1123 1129 1123 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1131 1139 1131 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 1197 1203 1197 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1432 1438 1432 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1496 1500 1496 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 1523 1529 1519 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1531 1537 1527 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 1542 1548 1538 1544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 1609 1618 1605 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6B</xref>
###xml 1679 1687 1675 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 1748 1754 1744 1750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1773 1779 1769 1775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1836 1844 1832 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 1849 1858 1845 1854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6B</xref>
###xml 1914 1920 1910 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1970 1975 1966 1971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR</italic>
###xml 2021 2027 2017 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 2058 2064 2054 2060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 2066 2074 2062 2070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 2079 2088 2075 2084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6B</xref>
###xml 2144 2150 2140 2146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2166 2170 2162 2166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 2215 2221 2207 2213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 2237 2246 2229 2238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g006">Figure 6B</xref>
###xml 2325 2329 2317 2321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 2494 2500 2486 2492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2510 2518 2502 2510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g001">Figure 1</xref>
###xml 2616 2622 2608 2614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
To determine the effect of distinct mutated CgPDR1 alleles on ABC-transporter genes expression, mRNA levels of CgCDR1, CgCDR2 and CgSNQ2 were determined by real-time RT-PCR in 21 matched pairs of azole-susceptible and azole-resistant isolates clinical isolates listed in Table 1 (Figure 1). As previously observed by Torelli et al.[17], CgCDR1, CgCDR2 and CgSNQ2 were not always coordinately expressed in azole-resistant isolates. Among them, CgSNQ2 showed in general the lowest expression variations. Taking a significant upregulation between two isolates as a threshold of two-fold expression difference, only nine isolates were above this value. CgSNQ2 was more upregulated (8.5-fold) than the other ABC transporters only in DSY2277 (Figure 1). Upregulation of CgCDR1 and CgCDR2 in azole-resistant isolates followed similar patterns but without reaching statistical significance (data not shown). In some cases, significant upregulation (from 13- to 170-fold) of only CgCDR1 was measured (DSY2268, DSY2273, DSY754, DSY2315, DSY565 and DSY2746). In two cases (DSY2254 and DSY2234), CgCDR2 upregulation outreached that of CgCDR1 (Figure 1). Since the three ABC-transporter genes are regulated by CgPDR1, their uncoordinated expression might be explained by either differences in their promoter sequences or by differences in the transcriptional capacity of CgPdr1p. To avoid differences due to strain genetic backgrounds, pairs of CgPDR1 alleles were reintroduced in the same background (DSY562 pdr1Delta). mRNA levels of CgCDR1, CgCDR2 and CgSNQ2 were measured by real-time RT-PCR in the revertant strains (Figure 6B) and compared with those obtained in the clinical isolates (Figure 1). For example, the presence of the Y584C substitution (from CgPDR1 of DSY754) led to CgCDR1 upregulation only (17- and 12-fold expression increase, Figure 1 and Figure 6B), whereas the presence of the T588A substitution (from CgPDR1 of DSY2234) resulted in high mRNA levels of both CgCDR genes (4- and 8-fold expression increase for CgCDR1, 23- and 30-fold increase for CgCDR2, Figure 1 and Figure 6B). Finally the presence of the P822L substitution (from CgPDR1 of BPY55) in a pdr1Delta mutant resulted in the upregulation of CgSNQ2 only (15-fold, Figure 6B), which is consistent with previous observation made in this clinical isolate [17]. These results as well as those obtained with other engineered isolates were overall consistent with expression profiles from clinical isolates containing the same CgPDR1 alleles (Figure 1) and thus indicate that ABC-transporter genes might be differentially regulated depending on the CgPDR1 GOF mutation and independently on the strain background.
###end p 39
###begin title 40
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 64 75 64 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 64 75 <span type="species:ncbi:5478">C. glabrata</span>
CgPDR1 GOF Mutations Are Responsible for Increased Virulence of C. glabrata
###end title 40
###begin p 41
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 430 441 430 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Barchiesi1">[20]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-MacCallum1">[22]</xref>
###xml 860 871 860 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 4 15 <span type="species:ncbi:5478">C. glabrata</span>
###xml 187 195 <span type="species:ncbi:9606">patients</span>
###xml 430 441 <span type="species:ncbi:5478">C. glabrata</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
###xml 860 871 <span type="species:ncbi:5478">C. glabrata</span>
The C. glabrata isolates analysed in this study are of clinical origin. These isolates may have adapted to the host conditions in order to cause disease. Moreover, azole therapy in these patients selected for azole-resistant isolates and ultimately led to treatment failure. One interesting and unresolved question is whether CgPDR1 mutations responsible for high transporter expression have an impact on virulence and fitness of C. glabrata under host conditions. We therefore first measured tissue fungal burdens in animal models using tail-vein injections in groups of immuno-competent and immuno-suppressed mice according to previously established protocols [20]-[22]. Fungal loads in kidneys, spleen and liver of all mice were measured seven days after infection. We next performed virulence assays by measuring mice survival after infection with several C. glabrata isolates to challenge correlations between virulence and possible differences in tissue fungal loads.
###end p 41
###begin p 42
###xml 77 93 77 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7A and 7B</xref>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
###xml 368 377 368 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s004">Figure S4</xref>
###xml 541 550 541 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g008">Figure 8A</xref>
###xml 783 789 783 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 926 932 926 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1023 1029 1019 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1124 1130 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1445 1454 1413 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7A</xref>
###xml 1456 1457 1424 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1516 1525 1484 1493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7B</xref>
###xml 1527 1528 1495 1496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1672 1673 1636 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1739 1740 1695 1696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1887 1896 1843 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g008">Figure 8A</xref>
###xml 1979 1985 1935 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2179 2185 2135 2141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2295 2303 2243 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7</xref>
###xml 2308 2317 2256 2265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g008">Figure 8B</xref>
###xml 2432 2438 2380 2386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2470 2476 2418 2424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2595 2603 2539 2547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7</xref>
###xml 2608 2617 2552 2561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g008">Figure 8A</xref>
###xml 2713 2719 2657 2663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 1261 1265 <span type="species:ncbi:10090">Mice</span>
###xml 1510 1514 <span type="species:ncbi:10090">mice</span>
###xml 1619 1623 <span type="species:ncbi:10090">mice</span>
Using first DSY562 and DSY565 in immuno-competent or immuno-suppressed mice (Figure 7A and 7B), our results showed that fungal loads in kidneys were significantly increased in both mouse models infected with DSY565 as compared to DSY562 (P<0.0001 and P = 0.0007, respectively; see details in Table S3). The same trend was observed in fungal loads of spleen and liver (Figure S4). Higher fungal loads in tissues of mice infected with the azole-resistant isolate DSY565 correlated with a significant increased virulence as compared to DSY562 (Figure 8A). Taken together, these results demonstrate that the azole-resistant isolate (DSY565) was more virulent than its azole-susceptible parent, DSY562. Since DSY562 and DSY565 differ at least by the presence of the L280F substitution in CgPDR1, it was tempting to test whether this substitution was responsible for this behavior. We therefore replaced the mutated allele with the CgPDR1 wild type allele in DSY565 (named as DSY565 pdr1Delta-PDR1; SFY118) and also replaced the CgPDR1 wild type allele with the mutated allele in DSY562 (named as DSY562 pdr1Delta-L280F; SFY115). CgPDR1 alleles were also reconstituted in their original backgrounds (DSY562 pdr1Delta-PDR1; SFY114 and DSY565 pdr1Delta-L280F; SFY119). Mice infected with DSY562 pdr1Delta-L280F or DSY565 pdr1Delta-L280F had significant higher fungal loads in their kidneys as compared to DSY565 pdr1Delta-PDR1 or DSY562 pdr1Delta-PDR1 (Figure 7A, P<0.0001). The same was observed in immuno-suppressed mice (Figure 7B, P<0.0001). No significant changes in kidneys fungal loads occurred between immuno-competent mice infected with DSY562 and DSY562 pdr1Delta-PDR1 (P = 0.07) or with DSY562 pdr1Delta-PDR1 and DSY565 pdr1Delta-PDR1 (P = 0.62). Virulence assays with the same strains confirmed the association of increased virulence with increased fungal loads of infected tissues (Figure 8A). Thus, increased virulence was associated with the presence of a GOF mutation in CgPDR1 independently on the strain background. Introducing other mutations in the background of DSY562 mimicked results of fungal tissue burdens and of virulence assays obtained with the first tested CgPDR1 mutant allele (see results obtained with DSY562 pdr1Delta-T588A, -Q1083Q, -P822L and DSY562 pdr1Delta-P822L, Figure 7 and Figure 8B) and thus one can predict that increased virulence may be caused by any of the GOF mutations so far identified in CgPDR1. Interestingly, the absence of CgPDR1 in DSY562 (DSY562 pdr1Delta; SFY92) did not significantly alter fungal tissue burdens and virulence in animal models (Figure 7 and Figure 8A). This strongly suggests that it is rather the presence of a GOF mutation than the presence of CgPDR1 that directly affects virulence.
###end p 42
###begin title 43
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 0 11 <span type="species:ncbi:5478">C. glabrata</span>
###xml 30 36 <span type="species:ncbi:10090">murine</span>
C. glabrata tissue burdens in murine infection models.
###end title 43
###begin p 44
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 121 132 121 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 491 492 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 636 640 636 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 758 762 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 858 864 850 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1044 1052 1036 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
###xml 1199 1200 1191 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1217 1228 1209 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1340 1342 1332 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 121 132 <span type="species:ncbi:5478">C. glabrata</span>
###xml 142 146 <span type="species:ncbi:10090">Mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
###xml 1217 1228 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
###xml 1424 1428 <span type="species:ncbi:10090">Mice</span>
(A) Fungal tissue burdens in kidneys from immuno-competent BALB/c mice infected intravenously with 4x107 viable cells of C. glabrata strains. Mice were sacrificed at day 7 post-infection; and results, which are expressed as CFUs per gram of tissue, represent values recorded separately for each of the ten mice. Geometric means are indicated by horizontal bars and asterisks indicate statistically significant differences (*: P<0.05; **: P<0.01; ***: P<0.001). NS indicates no significance (P>0.05). The origin of each strain is indicated. Strain background (DSY562 or DSY565) is indicated by filled or empty symbols, respectively. The pdr1Delta mutants from strains DSY562 and DSY565 correspond to SFY92 and SFY94, respectively. Revertants constructed from pdr1Delta mutants are indicated by the re-introduced GOF mutation or by the re-introduced wild type CgPDR1 allele from DSY562. Prism 5.0 was used for statistical analysis and data were processed with non-parametric Wilocoxon Rank sum tests. Comparisons are indicated in the Figure (see Table S3 for details) and associate selected data points. (B) Fungal tissue burdens in kidneys from immuno-suppressed mice infected intravenously with 4x107 viable cells of C. glabrata strains. BALB/c mice were rendered neutropenic by intraperitoneal administration of cyclophosphamide (200 mg kg-1 of body weight per day) three days before challenge and on the day of infection. Mice were sacrificed at day 7 post-infection.
###end p 44
###begin title 45
###xml 13 24 13 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 41 47 41 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 13 24 <span type="species:ncbi:5478">C. glabrata</span>
Virulence of C. glabrata is dependent on CgPDR1 GOF mutations.
###end title 45
###begin p 46
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 367 373 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 509 515 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 550 551 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
(A) Survival curves of mice infected with DSY562 and DSY565 and derived mutants and revertants. Statistical differences were performed using the Log-rank Mantel-Cox test (Prism 5.0) by comparing survival curves of mice infected by DSY562 and by other strains as indicated. The range of significant P values obtained is indicated for DSY565 and strains containing the CgPDR1 allele with a L280F substitution. (B) Survival curves of mice infected with DSY562 and DSY565 and strains reconstituted with different CgPDR1 alleles. The range of significant P values obtained is indicated for DSY565 and strains containing GOF mutations.
###end p 46
###begin p 47
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 70 77 70 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 179 185 175 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 286 294 278 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 299 310 291 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 458 467 450 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g009">Figure 9A</xref>
###xml 481 488 473 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 752 761 744 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g009">Figure 9B</xref>
###xml 804 810 796 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 848 855 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 299 310 <span type="species:ncbi:5478">C. glabrata</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
This assumption is also based on fitness tests performed in vitro and in vivo with two selected isolates, each containing a wild type (DSY562 pdr1Delta-PDR1; SFY114) or a mutated CgPDR1 allele (DSY562 pdr1Delta-L280F; SFY115). We observed that a GOF mutation had no selective advantage in vitro for C. glabrata over a susceptible parent isolate since both strains cultivated over 24 h at a 1:1 population ratio remained in equivalent population proportions (Figure 9A). It is only in vivo that the azole-resistant population displayed a selective advantage over susceptible isolates. After inoculating mice with a 1:1 population ratio, a progressive disappearance of the susceptible population was visible over the time lapse of the animal experiment (Figure 9B). These results demonstrate that a GOF in CgPDR1 is associated with a gain in fitness in vivo even in the absence of drug selection.
###end p 47
###begin title 48
Fitness assays between azole-resistant and azole-susceptible isolates.
###end title 48
###begin p 49
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 361 381 353 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 387 394 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 582 602 566 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
(A) In vitro fitness assays. Strains SFY114 (DSY562 pdr1Delta-PDR1) and SFY115 (DSY562 pdr1Delta-L280F) were inoculated in YEPD in single or mixed (1:1) cultures. Aliquots were taken from each culture in triplicate and population ratios were calculated from the proportion of azole-susceptible and azole-resistant colonies plated onto YEPD agar as described in Material and Methods. (B) In vivo fitness assays. SFY114 (DSY562 pdr1Delta-PDR1) and SFY115 (DSY562 pdr1Delta-L280F) were inoculated intravenously as single or mixed (1:1) cultures to three groups of mice as described in Material and Methods. Kidneys were taken at given time points from sacrificed mice and population ratios were measured as described above.
###end p 49
###begin title 50
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
CgPDR1 GOF Mutations Affect the In Vivo Response to Fluconazole
###end title 50
###begin p 51
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 381 390 381 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s005">Figure S5</xref>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 449 440 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g010">Figure 10</xref>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 705 711 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 906 914 906 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1001 1010 1001 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g005">Figure 5C</xref>
###xml 1032 1038 1032 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1072 1083 1072 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1109 1116 1109 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1194 1200 1194 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1396 1405 1388 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g010">Figure 10</xref>
###xml 1454 1455 1442 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1504 1510 1492 1498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1884 1885 1860 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2182 2188 2158 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2218 2229 2194 2205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2307 2313 2283 2289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 1072 1083 <span type="species:ncbi:5478">C. glabrata</span>
###xml 2218 2229 <span type="species:ncbi:5478">C. glabrata</span>
Since DSY565 is resistant to azoles in vitro, we expected little changes between tissue burden of mice infected with this clinical isolate in fluconazole-treated or -untreated conditions. The data obtained after measurement of colony forming units (CFU) from tissues of treated versus untreated animals infected with this strain confirmed this hypothesis only in spleen and liver (Figure S5, P = 0.39 and 0.82), while partially in kidneys (Figure 10, P = 0.04). These results contrasted with those obtained with the azole-susceptible isolate DSY562: a sharp and significant decrease of fungal load was observed in all organs when comparing treated versus untreated animals (P<0.0001-0.03). The absence of CgPDR1 in both DSY562 and DSY565 backgrounds resulted in this experimental setting in a three-log decrease of fungal loads when animal were treated with fluconazole. This result could be expected from in vitro susceptibility data that yielded for these mutants the lowest fluconazole MIC values (Figure 5C). This suggests that CgPDR1 is essential for the response of C. glabrata to fluconazole challenge in vivo. Reconstituting wild type isolates from DSY562 and DSY565 backgrounds with a CgPDR1 wild type allele (DSY562 pdr1Delta-PDR1: SFY114; DSY565 pdr1Delta-PDR1: SFY118) gave in terms of fluconazole efficacy similar results to those obtained with the starting clinical isolate DSY562 (Figure 10). With the exception of DSY562 pdr1Delta-T588A (P = 0.02), the reconstitution of GOF mutations in CgPDR1 in both DSY562 (DSY562 pdr1Delta-Q1083Q, -P822L) and DSY565 (DSY565 pdr1Delta-L280F, -P822L) gave by CFU counts in kidneys no significant differences between fluconazole-treated and untreated animals. However, CFU counts of spleen and liver of animals infected with DSY562 pdr1Delta-T588A were not significantly different from untreated animals upon fluconazole treatment (P = 0.28 and 0.16), thus suggesting that this GOF was still responsible for treatment failure. Taken together, our results are in agreement with the idea that high fluconazole MIC values are mirrored by treatment failure in this animal model. Moreover, our results demonstrate the critical role of CgPDR1 for the adequate response of C. glabrata to fluconazole challenge. On the other hand, our results also highlight that CgPDR1 GOF mutations alone are responsible for fluconazole treatment failure in the experimental model tested here.
###end p 51
###begin title 52
###xml 31 42 31 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 31 42 <span type="species:ncbi:5478">C. glabrata</span>
Efficacy of azole treatment in C. glabrata assessed by fungal tissue burden in kidneys.
###end title 52
###begin p 53
###xml 116 136 116 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 706 714 706 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g007">Figure 7</xref>
###xml 719 727 719 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">Mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
Fluconazole (100 mg/Kg/day) was administered by intraperitoneal injection in immuno-suppressed mice as described in Material and Methods. Treatment was initiated 24 h after inoculation (day 1 post-infection) and continued until day 7 post-infection. Mice were injected with 4x107 CFU of each investigated strain and organ homogenates were obtained from ten mice per group that were sacrificed and necropsied on day 8 post-infection. Results, which are expressed as CFUs per gram of tissue, represent means of values recorded separately for each of the mice. Geometric means are indicated by horizontal bars and asterisks indicate statistically significant differences between two conditions (see legend of Figure 7 and Table S3 for details). Closed and empty circles indicate CFU from untreated and fluconazole-treated animals infected with a DSY562 background, respectively. Closed and empty diamonds indicate CFU from untreated and fluconazole-treated isolates with a DSY565 background, respectively.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 103 109 103 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 176 187 176 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 327 333 327 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 346 352 346 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 176 187 <span type="species:ncbi:5478">C. glabrata</span>
CgPdr1p is a Zn(2)-Cys(6) transcription factor involved in the regulation of the ABC-transporter genes CgCDR1, CgCDR2 and CgSNQ2, which are responsible for azole resistance in C. glabrata. Four single amino acid substitutions in CgPdr1p (W297S, F575L, P822L and P927L) have been reported to increase the expression of at least CgCDR1, CgCDR2 and CgSNQ2 and thus to contribute to azole resistance of clinical isolates [14],[15]. This work allowed the identification of 57 additional substitutions in CgPdr1p localized in three main "hot spots" near the so-called inhibitory domain, the MHR and the transcriptional activation domain.
###end p 55
###begin title 56
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
CgPDR1: The Expected and the Non-Expected
###end title 56
###begin p 57
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 281 292 281 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 562 575 562 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 620 624 620 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR3</italic>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Delaveau1">[23]</xref>
###xml 742 746 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR1</italic>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Carvajal1">[24]</xref>
###xml 898 904 898 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1234 1238 1234 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR3</italic>
###xml 1252 1265 1252 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 281 292 <span type="species:ncbi:5478">C. glabrata</span>
###xml 562 575 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1252 1265 <span type="species:ncbi:4932">S. cerevisiae</span>
Nine distinct mutations in CgPDR1 alleles, three in each of the "hot spots" domains, conferred constitutive upregulation of ABC-transporter genes when expressed in an azole-susceptible background and thus can be considered as true GOF mutations responsible for azole resistance in C. glabrata. The 48 other mutations are also likely GOF mutations since they are present only in alleles isolated from azole-resistant strains upregulating ABC-transporter genes and the localization of these mutations along the protein is similar to GOF mutations described in the S. cerevisiae homologs Pdr1p/Pdr3p. Most GOF mutations in PDR3 map to the first two motifs of the inhibitory domain and to the transcriptional activation domain [23]. In contrast, PDR1 mutations are scattered throughout the entire protein with some "hot spots" at the C-terminus [24]. Given the high diversity of GOF mutations found in CgPDR1, it is unlikely that all mutations affect similarly the transcriptional activity of CgPdr1p that is responsible for ABC-transporter genes overexpression. Hence, GOF mutations in the inhibitory domain might impair transcriptional inhibition and those in the transcriptional activation might induce hyperactivation as proposed for PDR3 mutations in S. cerevisiae.
###end p 57
###begin p 58
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Thakur1">[16]</xref>
###xml 269 282 269 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 948 952 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Thakur1">[16]</xref>
###xml 269 282 <span type="species:ncbi:4932">S. cerevisiae</span>
The effect of some of the identified GOF mutations might be enlightened by the recent finding that CgPdr1p acts as nuclear receptor by directly binding to azoles in order to activate expression of efflux pumps genes [16]. For instance, the xenobiotic binding domain of S. cerevisiae Pdr1p has been mapped between amino acids 352 and 543, and this domain corresponds by sequence alignment to the MHR region of CgPdr1p. GOF mutations in the MHR might bypass the requirement of xenobiotic binding that is otherwise necessary to activate the transcription of efflux pumps genes. Determining whether CgPDR1 alleles containing mutations in the MHR domain could still be induced by azoles may verify this hypothesis. Once bound to azoles, CgPdr1p forms a complex with the Mediator co-activator subunit CgGal11p though the KIX motif to activate transcription of target genes. The CgPdr1p KIX-binding domain has been mapped between amino acids 1074 to 1104 [16]. Interestingly, we identified nine different GOF mutations within this short motif, suggesting that GOF mutations might modify CgGal11p recruitment in absence of drug binding.
###end p 58
###begin p 59
###xml 32 45 32 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR5</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNQ2</italic>
###xml 289 293 289 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YOR1</italic>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-MacPherson1">[25]</xref>
###xml 302 313 302 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 435 455 435 455 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCC(GA)(CT)GAA-3&#8242;</named-content>
###xml 497 508 497 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 558 564 558 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 577 583 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 744 750 744 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 755 761 755 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 900 906 900 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1181 1187 1181 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1644 1650 1644 1650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1665 1671 1665 1671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 1676 1682 1676 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 2049 2055 2049 2055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2230 2236 2230 2236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 32 45 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 302 313 <span type="species:ncbi:5478">C. glabrata</span>
###xml 497 508 <span type="species:ncbi:5478">C. glabrata</span>
It is now well established that S. cerevisiae Pdr1p and Pdr3p act through cis acting sites present in the promoters of target genes. The consensus motif is named PDRE (for pleiotropic drug resistance element) and is present in several ABC-transporter gene promoters such as PDR5, SNQ2 and YOR1[25]. In C. glabrata, a genome-wide study identified genes upregulated by a CgPDR1 GOF mutant and, by analysis of the promoters, the sequence 5'-TCC(GA)(CT)GAA-3' was identified as a strong candidate for C. glabrata PDRE. This sequence is found in the promoters of CgCDR1, CgCDR2 and CgSNQ2, suggesting that CgPdr1p binds directly to PDRE sequences to regulate transcription of target genes [14],[15],[17]. Surprisingly, our results show that CgCDR1, CgCDR2 and CgSNQ2 are not coordinately expressed in azole-resistant isolates. Moreover, the selective upregulation of efflux pump genes is dependent on the CgPDR1 GOF alleles, since expression of distinct mutated alleles in the same genetic background restored the ABC-transporter gene expression of the parental clinical strains from which the alleles were isolated. This observation highlights still underscored and novel functions of CgPDR1 on the regulation of target genes. One possible explanation for these differentiated effects could be the localization of the mutations that may alter the transcriptional activity of CgPdr1p. However, data presented here indicate that mutations within the same domain do not yield similar ABC-transporter expression patterns. For example, two distinct mutations in the KIX domain, E1083Q (in DSY530) and D1082G (in DSY2254), gave selective upregulation of CgCDR1 alone or both CgCDR1 and CgCDR2, respectively. On the other hand, differences in the number and/or sequence of the PDRE present in the efflux pump promoters could influence CgPdr1p regulatory activity. Alternatively, the function of CgPdr1p might be subjected to regulation by other transcription factors. Irrespective of the precise molecular mechanism involved, our results strongly suggest that CgPDR1 GOF mutations have differentiated effects on target genes including the major ABC-transporters involved in azole resistance. Microarray experiments performed with individual CgPDR1 mutations would help determining whether other target genes are differentially expressed and promoter analysis may provide clues to uncover this mechanism.
###end p 59
###begin p 60
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR3</italic>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Delahodde1">[26]</xref>
###xml 226 232 226 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Tsai1">[15]</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 435 441 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 592 598 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 652 658 652 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 757 763 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 821 832 821 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Gygax1">[27]</xref>
###xml 1011 1017 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 821 832 <span type="species:ncbi:5478">C. glabrata</span>
The presence of a PDRE sequence in the promoter of CgPDR1 as well as the constitutive high expression of CgPDR1 in some azole-resistant isolates suggested an auto-regulation similarly to PDR3[14],[15],[26]. Moreover, enhanced CgPDR1 expression was also observed in some petite mutants [15]. It has thus been proposed that CgPDR1 may regulate its own expression leading to azole resistance. However, results presented here suggest that CgPDR1 upregulation is restricted to a limited number of azole-resistant isolates and does not correlate with the presence of GOF mutations. The increase in CgPDR1 expression observed in our strains is not sufficient per se to induce azole resistance. This observation is consistent with a recent study demonstrating that CgPDR1 expression is poorly correlated with azole resistance in C. glabrata[27]. Even though our experimental approaches were different from published studies, especially with respect to the engineering of mutant and revertant strains, the regulation of CgPDR1 needs to be further investigated.
###end p 60
###begin title 61
###xml 22 33 22 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 22 33 <span type="species:ncbi:5478">C. glabrata</span>
CgPDR1 and Effects on C. glabrata-Host Interactions
###end title 61
###begin p 62
###xml 98 109 98 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Anderson1">[28]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Andersson1">[29]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Warner1">[30]</xref>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Gagneux1">[31]</xref>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Anderson1">[28]</xref>
###xml 1056 1067 1056 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans</italic>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Graybill1">[32]</xref>
###xml 1296 1304 1296 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1336 1347 1336 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans</italic>
###xml 1676 1680 1676 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Cowen1">[33]</xref>
###xml 1788 1792 1788 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Marr1">[34]</xref>
###xml 1793 1797 1793 1797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Martins1">[36]</xref>
###xml 98 109 <span type="species:ncbi:5478">C. glabrata</span>
###xml 198 203 <span type="species:ncbi:4932">yeast</span>
###xml 1056 1067 <span type="species:ncbi:5476">C. albicans</span>
###xml 1336 1347 <span type="species:ncbi:5476">C. albicans</span>
During the last decades, there has been a significant increase in the appearance of resistance in C. glabrata as a result of an increased use of azoles combined with the exceptional ability of this yeast species to develop resistance. In bacteria, antimicrobial resistance is often associated with fitness costs and thus results in a competitive disadvantage against otherwise drug-susceptible bacteria within the host [28]. Restoration of fitness in drug-resistant bacteria is often associated with the emergence of compensatory mutations [29]. A few examples illustrate that mutations in genes involved in antibiotic resistance can be beneficial in the fitness of pathogenic bacteria [30],[31]. Implicit in this reasoning is that antifungal resistance may have fitness costs in fungi and thus may result in a counter-selection against resistant strains without drug pressure. Whether resistance similarly exerts a relevant fitness cost that is associated with diminished virulence in fungi is still debated [28]. One study has addressed this question in C. albicans by testing the virulence of azole-resistant isolates compared to their azole-susceptible parental isolate [32]. The authors concluded that no direct relationship exists between the development of azole resistance and virulence. In vitro studies showed that individual C. albicans colonies subcultured in fluconazole-containing medium can follow individual emergence of azole resistance mechanisms. Some of these trajectories can be associated with an immediate decrease in fitness (measured by reduced growth rate). However fitness is restored by further cultivation by still unknown compensatory mechanisms [33]. Other studies suggest that once the selective pressure eases, the fungal-resistant strains will disappear [34]-[36].
###end p 62
###begin p 63
###xml 30 41 30 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 149 160 149 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Arendrup1">[37]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Brieland1">[38]</xref>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 508 509 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 625 636 625 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans</italic>
###xml 638 649 638 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 751 755 751 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Kaur1">[21]</xref>
###xml 908 919 908 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1000 1008 1000 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1009 1016 1009 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1138 1147 1138 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g009">Figure 9B</xref>
###xml 1351 1357 1351 1357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1422 1433 1422 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1451 1455 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ace2</italic>
###xml 1534 1538 1530 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Kamran1">[39]</xref>
###xml 1642 1648 1638 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1769 1792 1765 1788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 1850 1854 1846 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PKR1</italic>
###xml 1928 1932 1924 1928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-DSouza1">[40]</xref>
###xml 1952 1963 1948 1959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2048 2055 2044 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2118 2125 2114 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2201 2212 2197 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2341 2352 2337 2348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2435 2446 2431 2442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 2490 2493 2486 2489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Bennett1">[4]</xref>
###xml 2494 2498 2490 2494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanguinetti1">[13]</xref>
###xml 2748 2754 2744 2750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 2779 2790 2775 2786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 30 41 <span type="species:ncbi:5478">C. glabrata</span>
###xml 149 160 <span type="species:ncbi:5478">C. glabrata</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 625 636 <span type="species:ncbi:5476">C. albicans</span>
###xml 638 649 <span type="species:ncbi:5478">C. glabrata</span>
###xml 908 919 <span type="species:ncbi:5478">C. glabrata</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
###xml 1422 1433 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1769 1781 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 1769 1792 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 1952 1963 <span type="species:ncbi:5478">C. glabrata</span>
###xml 2201 2212 <span type="species:ncbi:5478">C. glabrata</span>
###xml 2225 2233 <span type="species:ncbi:9606">patients</span>
###xml 2341 2352 <span type="species:ncbi:5478">C. glabrata</span>
###xml 2435 2446 <span type="species:ncbi:5478">C. glabrata</span>
###xml 2779 2790 <span type="species:ncbi:5478">C. glabrata</span>
Testing the interplay between C. glabrata and the host requires a validated animal model. Existing studies have mostly used intravenous injection of C. glabrata at varying doses (107 to 108 cells per mouse) with different immune system status (immuno-competent and immuno-suppressed) and in different mice backgrounds [37],[38]. Depending on the initial infection doses and the mice genetic background, not only CFU counts in target organs (kidneys, spleen and liver) differed by several logs (from 105 to 108 CFU per g infected tissue) over the duration of the experiments but also mice survival was varying. As compared to C. albicans, C. glabrata was consistently much less pathogenic. In our study, we have followed protocols established recently [17],[21] and used different immune status regimen to enable valid conclusions on the relationship between azole resistance and virulence. Our findings that C. glabrata resistant strains are both more virulent in mice and less susceptible to azoles in vitro/in vivo as compared to wild type isolates strongly suggest a gain in fitness for the resistant isolates. As shown in this study (Figure 9B), the azole-resistant population did effectively take over the azole-susceptible isolates in the absence of drug selection. We showed that it is the presence of GOF mutations rather than the presence of CgPDR1 that accounts for increased virulence. On the opposite to known C. glabrata mutants (such as ace2Delta) for which hypervirulence was associated with formation of pseudo-hyphae [39], the morphology of azole-resistant isolates tested here was not altered and therefore GOF mutations in CgPDR1 are likely to account for the observed phenotype. Hypervirulence has been also observed in other fungal species such as Cryptococcus neoformans where perturbation in cAMP signalling by inactivation of PKR1 (encoding the PKA regulatory subunit) resulted in capsule overproduction [40]. Even though other C. glabrata infection models remain to be tested, this is to our knowledge the first example of in vivo acquired mutations in a fungal gene with a positive impact on in vivo fitness. This highlights a need of carefully monitoring drug resistance of C. glabrata in infected patients, since increased virulence observed here may also have a negative impact on the outcome of the disease. In C. glabrata, the gain in fitness may have favoured an important proportion of azole-resistant C. glabrata isolates with ABC transporter upregulation [4],[13]. This is in contrast with studies on molecular epidemiology of drug resistance performed with other fungal pathogens, where resistance develops by more diverse resistance mechanisms, thus raising the question whether the gain of fitness mediated by CgPDR1 is a feature unique for C. glabrata. It will be therefore interesting to test whether transcriptional activators of drug resistance genes have similar effects on virulence and fitness in other important fungal pathogens.
###end p 63
###begin p 64
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 133 144 133 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Vermitsky2">[14]</xref>
###xml 643 654 643 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 133 144 <span type="species:ncbi:5478">C. glabrata</span>
###xml 643 654 <span type="species:ncbi:5478">C. glabrata</span>
How CgPDR1 GOF mutations may affect virulence is still unknown. Nevertheless, published microarray experiments comparing a wild type C. glabrata isolates with a resistant strain expressing a mutated form of CgPdr1p may help identifying genes having a putative role in the virulence on the basis of differentially expressed genes [14]. Even though the number of differentially regulated genes is high in this study, several genes involved in stress response, resistance to DNA damage and cell wall structure are upregulated in the azole-resistant isolate, all of which may contribute individually or in combination to modulate the virulence of C. glabrata. Further studies are therefore necessary to address the involvement of these genes in virulence.
###end p 64
###begin p 65
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g010">Figure 10</xref>
###xml 302 311 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s005">Figure S5</xref>
###xml 372 383 372 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 518 529 518 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 618 629 618 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 779 790 779 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Ju1">[41]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Gumbo1">[44]</xref>
###xml 916 927 916 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1069 1080 1069 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1189 1197 1189 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1246 1253 1246 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1291 1297 1291 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1523 1529 1523 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1572 1578 1572 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1633 1644 1633 1644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1789 1795 1789 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1837 1843 1837 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1939 1943 1939 1943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Thakur1">[16]</xref>
###xml 1944 1948 1944 1948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Goffeau1">[45]</xref>
###xml 1986 1992 1986 1992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 111 117 <span type="species:ncbi:10090">murine</span>
###xml 372 383 <span type="species:ncbi:5478">C. glabrata</span>
###xml 398 403 <span type="species:ncbi:9606">human</span>
###xml 518 529 <span type="species:ncbi:5478">C. glabrata</span>
###xml 618 629 <span type="species:ncbi:5478">C. glabrata</span>
###xml 779 790 <span type="species:ncbi:5478">C. glabrata</span>
###xml 916 927 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1069 1080 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1633 1644 <span type="species:ncbi:5478">C. glabrata</span>
Our results demonstrate that CgPDR1 GOF mutations alone are responsible for fluconazole treatment failure in a murine model. In most cases, animals infected with isolates containing GOF mutations were not responding to fluconazole treatment on the basis of CFU counts in specific organs (Figure 10 and Figure S5). Fluconazole is not considered as a therapeutic option for C. glabrata infections in human but served here as a compound to test the effect of GOF mutations on treatment outcome. Our results showed that a C. glabrata isolate with a low azole MIC can still respond to fluconazole treatment. A reduction of C. glabrata CFU counts in the range observed in the present study in azole-treated animals (approximately 1.5 logs) is not consistently reported in experimental C. glabrata candidiasis [41]-[44]. These variations probably reflect the technical difficulties behind the establishment of a disease by C. glabrata in different animal models but could also be the result of inappropriate drug regimen. Having determined conditions necessary to establish a C. glabrata infection and to respond to drug treatment by a corresponding drug dosage, our study could demonstrate that in vitro fluconazole resistance was well correlated with in vivo resistance. Because GOF mutations in CgPDR1 are also responsible for increased virulence, drug treatment faces the challenges of both higher fungal loads and acquired resistance. Under these conditions, the failure of drug treatment is more likely. Besides the role of CgPDR1 GOF mutations in azole treatment failure, CgPDR1 was shown to play a critical role for the response of C. glabrata during fluconazole treatment as observed by the sharp decrease in fungal tissue burden after treatment in animals infected with mutants lacking CgPDR1. Together with the recent discovery that CgPDR1 possesses functional domains used as drug ligands and therefore potential sites for inhibitors [16],[45], our data suggest that inhibition of CgPDR1 could shortcut fitness and potentiate azole therapy. Future studies are therefore necessary to explore this possibility.
###end p 65
###begin title 66
Materials and Methods
###end title 66
###begin title 67
Strains and Growth Media
###end title 67
###begin p 68
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 57 65 57 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s006">Table S1</xref>
###xml 111 122 111 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1149 1153 1137 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard3">[10]</xref>
###xml 1245 1256 1233 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1380 1382 1364 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1568 1584 1552 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 1768 1770 1744 1746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 4 15 <span type="species:ncbi:5478">C. glabrata</span>
###xml 111 122 <span type="species:ncbi:5478">C. glabrata</span>
###xml 206 214 <span type="species:ncbi:9606">patients</span>
###xml 866 871 <span type="species:ncbi:4932">yeast</span>
###xml 934 939 <span type="species:ncbi:4932">yeast</span>
###xml 1135 1140 <span type="species:ncbi:4932">yeast</span>
###xml 1164 1169 <span type="species:ncbi:4932">yeast</span>
###xml 1245 1256 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1429 1434 <span type="species:ncbi:4932">yeast</span>
###xml 1568 1584 <span type="species:ncbi:562">Escherichia coli</span>
The C. glabrata strains used in this study are listed in Table S1. One hundred twenty two clinical isolates of C. glabrata and were recovered from different specimens (e.g. blood, urine, vagina, sputum) of patients. Strains with the prefix "BPY" were collected at the Universita Cattolica del Sacro Cuore, Rome, Italy. Strains with the prefix "DSY" were collected at the University Hospital Center, Lausanne (Switzerland) except strains DSY1166, DSY1169, DSY1174, DSY1176, DSY1180, DSY1185 that were provided by from Nippon Roche Research (Kanagawa, Japan). Strains DSY2724, DSY2725, DSY2726, DSY2731, DSY2746 were obtained from J.-P. Bouchara at the Centre Hospitalier d'Angers (France) and strains DSY2769, DSY2770 from M.-E. Bougnoux at the Necker Hospital (Paris, France). Strains were stored in 20% glycerol stocks at -80degreesC and cultured on either YPD (1% yeast extract, 2% peptone, 2% glucose) or minimal medium YNB (0.67% yeast nitrogen base plus 2% glucose) at 30degreesC when necessary. For solid media, 2% agar was added. YNB with appropriate amino acids and bases was used as a selective medium after transformation of yeast strains [10]. YEPG (1% yeast extract, 2% peptone, 3% glycerol, 1% ethanol) agar plates was used to test C. glabrata strains for petite growth phenotype. YPD agar plates containing nourseothricin (clonNAT, Werner BioAgents) at 200 microg ml-1 were used as a selective medium for growth of yeast transformant strains. Drugs were obtained from the following sources: fluconazole (Pfizer), itraconazole and ketoconazole (Janssen). Escherichia coli DH5alpha was used as a host for plasmid construction and propagation. DH5alpha was grown in Luria-Bertani broth or on Luria-Bertani agar plates supplemented with ampicillin (0.1 mg ml-1) when required.
###end p 68
###begin title 69
Drug Susceptibility Assays
###end title 69
###begin p 70
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 250 251 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 260 262 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 626 637 618 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 821 825 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard3">[10]</xref>
###xml 4 15 <span type="species:ncbi:5478">C. glabrata</span>
###xml 626 637 <span type="species:ncbi:5478">C. glabrata</span>
###xml 719 724 <span type="species:ncbi:4932">yeast</span>
###xml 868 873 <span type="species:ncbi:4932">yeast</span>
The C. glabrata strains were tested for azole susceptibility with the broth microdilution method described in the CLSI (formerly NCCLS) document M27-A2 (National Committee for Clinical Laboratory Standards, 2002). Briefly, aliquots of 1.5 (+/-1.0)x103 cells ml-1 were distributed to wells of a microtitre plate in RPMI 1640 containing 2% glucose and incubated at 35degreesC for 48 h. Endpoint readings were recorded with an automatic plate reader (Multiskan Ascent, Thermo) and the lowest azole concentration that reduced growth to 50% of that of the drug-free control was defined as the MIC. Susceptibility to fluconazole of C. glabrata strains was tested qualitatively by spotting serial dilutions of overnight-grown yeast broth cultures onto YPD agar plates with different drug concentrations, as described previously [10]. After incubation at 30degreesC for 48 h, yeast spots were visualized onto plate surfaces.
###end p 70
###begin title 71
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Sequencing of CgPDR1
###end title 71
###begin p 72
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 104 142 104 142 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATACCAGAATTCGGTCTCCGCTACAGGTTATA-3&#8242;</named-content>
###xml 162 200 162 200 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGTTTGGATCCAACGTTGTTGAGAAGGTATT-3&#8242;</named-content>
###xml 0 11 <span type="species:ncbi:5478">C. glabrata</span>
C. glabrata genomic DNA was used as a template to amplify by PCR CgPDR1 using the primers CgPDR1-EcoRI (5'-ATACCAGAATTCGGTCTCCGCTACAGGTTATA-3') and CgPDR1-BamHI (5'-AAGTTTGGATCCAACGTTGTTGAGAAGGTATT-3'). The resulting PCR product was sequenced with the BigDye Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems) according to the manufacturer protocol.
###end p 72
###begin title 73
Immunoblotting
###end title 73
###begin p 74
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard4">[46]</xref>
###xml 196 199 196 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard2">[9]</xref>
###xml 0 11 <span type="species:ncbi:5478">C. glabrata</span>
C. glabrata cell extracts for immunoblotting were prepared by an alkaline extraction procedure as described previously [46]. Detection of CgCdr1p and CgCdr2p was performed as described previously [9]. Signals were revealed by exposure to Amersham Hyperfilm MP films (GE Healthcare).
###end p 74
###begin title 75
Quantitative Real-Time RT-PCR
###end title 75
###begin p 76
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanguinetti1">[13]</xref>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR2</italic>
###xml 270 276 270 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanguinetti1">[13]</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanguinetti1">[13]</xref>
###xml 828 834 828 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 872 876 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 887 888 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 998 1004 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 1134 1138 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 1154 1160 1154 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1371 1377 1371 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1437 1463 1437 1463 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCTTGCCGATAGTCATAC-3&#8242;</named-content>
###xml 1481 1507 1481 1507 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGGTCAGGGCATACTTCAG-3&#8242;</named-content>
###xml 1664 1670 1664 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1700 1706 1700 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 1764 1790 1764 1790 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTCCAGCCTTCTACGTTTCC-3&#8242;</named-content>
###xml 1808 1834 1808 1834 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCTACCAGCAAGGTCGATTC-3&#8242;</named-content>
Total RNA was extracted from log phase cultures with an RNeasy Protect Mini kit (Qiagen) by a process involving mechanical disruption of the cells with glass beads and an RNase-free DNase treatment step as previously described [13]. Expression of the CgCDR1, CgCDR2 and CgSNQ2 genes was quantitatively assessed with real-time RT-PCR in an i-Cycler iQ system (Bio-Rad). All primers and probes [13] were designed with Beacon Designer 2 (version 2.06) software (Premier Biosoft International) and synthesized by MWG Biotech (Ebersberg, Germany). RT-PCRs were carried out as previously described [13]. Each reaction was run in triplicate on three separate occasions. For relative quantification of the target genes, each set of primer pairs and the Taqman probes were used in combination with the primers and probe specific for the CgACT1 reference gene in separate reactions [17]. Changes (n-fold) in gene expression relative to that of DSY562 (azole-susceptible control isolate) were determined from CgACT1-normalized expression levels. A two-fold increase in the expression level of each gene was arbitrarily considered as significant [17]. Expression of CgPDR1 in related azole-susceptible and azole-resistant clinical isolates was determined by real-time RT-PCR in an ABI Prism 7000 (Applied Biosystems). Each reaction was run in triplicate on three separate occasions. CgPDR1 quantification was performed using the primers CgPDR1-for (5'-AGCCTTGCCGATAGTCATAC-3') and CgPDR1-rev (5'-AAGGTCAGGGCATACTTCAG-3') using the QuantiTect SYBR Green PCR Kit (Qiagen). CgPDR1 alleles sequenced in this work can be found under GenBank accession numbers FJ550215 to FJ550284. CgPDR1 expression was normalized by CgACT1 expression levels using the specific primers CgACT1-for (5'-TTCCAGCCTTCTACGTTTCC-3') and CgACT1-rev (5'-TCTACCAGCAAGGTCGATTC-3').
###end p 76
###begin title 77
RNA Hybridization
###end title 77
###begin p 78
###xml 34 45 34 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard3">[10]</xref>
###xml 387 389 373 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 721 727 707 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 831 872 817 858 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCAAAGCATGCATG CAAACATTAGAAACTACA-3&#8242;</named-content>
###xml 889 913 875 899 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCTTAAGCCCGATAAGG-3&#8242;</named-content>
###xml 920 926 906 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 1014 1040 1000 1026 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGACAACGGTTCCGGTATG-3&#8242;</named-content>
###xml 1055 1083 1041 1069 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCGCATTCCG TAGTTCTAAG-3&#8242;</named-content>
###xml 34 45 <span type="species:ncbi:5478">C. glabrata</span>
Small-scale isolation of RNA from C. glabrata was performed as previously described [10]. Five microg of denaturated RNA was transferred under vacuum onto GeneScreen Plus membranes (Perkin Elmer) using the slot-blotter MINIFOLD II (Schleicher & Schuell). Membranes were washed in 2x SSC and dried during 2 h at 80degreesC under vacuum. Probes were labelled by random priming with [alpha-32P]dATP using the Mega Labeling kit (GE Healthcare) according to the instructions of the manufacturer. Radioactive signals were revealed by exposure to Amersham Hyperfilm MP films (GE Healthcare). Signals obtained in blotted membranes were quantified by counting of radioactivity with the help of a Typhoon Trio (GE Healthcare). The CgPDR1 probe corresponds to the entire open reading frame and was generated by PCR using primers CgPDR1-SphI (5'-GCGCAAAGCATGCATG CAAACATTAGAAACTACA-3') and CgPDR1-10 (5'-TCCTTAAGCCCGATAAGG-3'). The CgACT1 probe was used as an internal standard and was generated by PCR using primers CgACT1F (5'-TTGACAACGGTTCCGGTATG-3') and CgACT1R (5'- CCGCATTCCG TAGTTCTAAG-3').
###end p 78
###begin title 79
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Expression of CgPDR1 Alleles in SFY53
###end title 79
###begin p 80
###xml 11 17 11 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
To express CgPDR1 alleles in an azole-susceptible strain, the CgPDR1 ORF flanked by 1.2 kb-upstream and 0.5 kb-downstream regions was amplified by PCR from DSY2235 and DSY2234 genomic DNA using the primers CgPDR1-EcoRI and CgPDR1-BamHI (see above) and inserted into pCgACU-5 to yield pSF18 and pSF19, respectively. These plasmids were used to transform SFY53 (DSY562 pdr1Delta) to obtain SFY72 and SFY73, respectively.
###end p 80
###begin title 81
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Disruption of CgPDR1
###end title 81
###begin p 82
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAT1</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 199 202 199 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 208 211 208 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 339 345 339 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
pSF2, in which the SAT1 flipper is flanked by CgPDR1 upstream and downstream sequences, was used for the disruption of CgPDR1 in DSY562 and DSY565 [17]. This plasmid was linearized by digestion with KpnI and SacI and transformed into DSY562 and DSY565 to obtain after selection of transformants on nourseothricin-containing YPD plates the CgPDR1 deletion strains SFY92 and SFY93, respectively.
###end p 82
###begin title 83
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Replacement of CgPDR1 Alleles
###end title 83
###begin p 84
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAT1</italic>
###xml 174 176 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 204 206 198 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 333 335 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 177 182 <span type="species:ncbi:4932">yeast</span>
###xml 207 213 <span type="species:ncbi:9913">bovine</span>
For CgPDR1 replacement in SFY92 and SFY94, FLP-mediated excision of the SAT1 cassette was first induced by growing the cells for 4 h at 30degreesC in YCB-BSA medium (23.4 g l-1 yeast carbon base and 4 g l-1 bovine serum albumin; pH 4.0). One hundred to 200 colonies were plated onto YPD plates containing nourseothricin (15 microg ml-1) and grown for 48 h at 30degreesC to obtain nourseothricin-sensitive strains SFY93 and SFY95, respectively.
###end p 84
###begin p 85
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 159 163 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAT1</italic>
###xml 193 199 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 245 252 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000268-t001">Table 1</xref>
###xml 277 281 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Torelli1">[17]</xref>
###xml 305 311 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 407 414 403 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000268-t001">Table 1</xref>
###xml 442 485 438 481 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCAAAGGTACCCGTTGATCATTATAATTGTGGGTAAA-3&#8242;</named-content>
###xml 508 551 504 547 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCAAAGAGCTCGAGTTACAGACGACCAACGTGTCG-3&#8242;</named-content>
###xml 666 708 662 704 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCAAAGAATTCGTTGAGAAGGTATTAAGAACTTC-3&#8242;</named-content>
###xml 731 776 727 772 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCAAAGCGGCCGCTACCGAAAGTTCGGTAAATCTAGG-3&#8242;</named-content>
###xml 823 826 819 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 833 836 829 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 862 865 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 868 871 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 893 897 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SAT1</italic>
###xml 952 955 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 961 964 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sac</italic>
###xml 1092 1098 1088 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1127 1135 1123 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s006">Table S1</xref>
The revertant strains generated in this study were obtained by transformation of the pdr1Delta mutants SFY93 and SFY95 with linearized plasmids containing the SAT1 marker and the PCR-amplified CgPDR1 open reading frames of the strains listed in Table 1 as described previously [17]. Briefly, the complete CgPDR1 ORF flanked by 500 bp was amplified by PCR from genomic DNA of the first eight strain pairs of Table 1 using primers CgPDR1-KpnI (5'-GCAAAGGTACCCGTTGATCATTATAATTGTGGGTAAA-3') and 3'UTR-PDR1-SacI (5'-GCGCAAAGAGCTCGAGTTACAGACGACCAACGTGTCG-3') and inserted into pBluescript II SK(+). These plasmids were amplified by PCR using the primers CgPDR1-EcoRI inv (5'-GCGCAAAGAATTCGTTGAGAAGGTATTAAGAACTTC-3') and 3'UTR-PDR1-NotI (5'-GCGCAAAGCGGCCGCTACCGAAAGTTCGGTAAATCTAGG-3'). The resulting PCR products were digested by EcoRI and NotI and ligated to a 1.8 kb EcoRI/NotI fragment containing SAT1 from pSFS1. The resulting plasmids were linearized by KpnI and SacI and transformed into SFY93 and SFY95 to obtain, after selection of transformants on nourseothricin-containing YPD plates, the CgPDR1 revertant strains listed in Table S1.
###end p 85
###begin title 86
Animal Studies
###end title 86
###begin p 87
###xml 293 304 293 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 390 401 390 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 293 304 <span type="species:ncbi:5478">C. glabrata</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 390 401 <span type="species:ncbi:5478">C. glabrata</span>
Female BALB/c mice (20 to 25 g; Harlan Italy S.r.l) were housed in filter-top cages with free access to food and water, and were used for all in vivo experiments with the approval by the institutional Animal Use Committee (Universita Cattolica del Sacro Cuore, Rome Roma, Italy). To establish C. glabrata infection, mice were injected into their lateral vein with saline suspensions of the C. glabrata strains (each in a volume of 200 microl).
###end p 87
###begin p 88
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Kaur1">[21]</xref>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 458 459 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 817 819 811 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 947 948 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 969 973 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-MacCallum1">[22]</xref>
###xml 1096 1097 1090 1091 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 67 72 <span type="species:ncbi:4932">yeast</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 215 221 <span type="species:ncbi:4932">yeasts</span>
###xml 228 232 <span type="species:ncbi:10090">Mice</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 870 874 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">Mice</span>
In virulence studies, a group of ten mice was established for each yeast strain. In a first experiment series, immuno-competent or immuno-suppressed mice were inoculated with 4x107 colony-forming units (CFU) of the yeasts [21]. Mice were rendered neutropenic by intraperitoneal administration of cyclophosphamide (200 mg kg-1 of body weight per day) three days before challenge and on the day of infection. After seven days, mice were sacrificed by use of CO2 inhalation, and target organs (liver, spleen and kidney) were excised aseptically, weighted individually and homogenized in sterile saline by using a Stomacher 80 device (Pbi International) for 120 s at high speed. Organ homogenates were diluted and plated onto YPD. Colonies were counted after two days of incubation at 30degreesC, and the numbers of CFU g-1 of organ were calculated. In a second experiment, mice were rendered neutropenic as above described and were injected with 7x107 CFUs of the strains [22]. Mice were monitored with twice-daily inspections and those that appeared moribund or in pain were sacrificed by use of CO2 inhalation.
###end p 88
###begin p 89
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Barchiesi1">[20]</xref>
###xml 250 251 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Barchiesi1">[20]</xref>
###xml 432 434 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Ju1">[41]</xref>
###xml 222 226 <span type="species:ncbi:10090">Mice</span>
###xml 373 377 <span type="species:ncbi:10090">Mice</span>
In fluconazole treatment studies, two groups of tenmice, one for drug treatment and one for control, were established with each strain. Neutropenia was induced as above described on days -4, +1 and +4 post-infection [20]. Mice were injected with 4x107 CFUs [20] of the strains and were sacrificed one day after the end of therapy to assess organ fungal burden (see above). Mice received daily intraperitoneal injections of 100 mg kg-1 fluconazole diluted in saline [41] and the treatment was initiated 24 h after challenge and continued through post-infection day 7.
###end p 89
###begin p 90
###xml 155 156 155 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 277 285 277 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
CFU counts were analysed with non-parametric Wilocoxon Rank sum tests, while mean survival times were compared among groups by using the long-rank test. A P-value of less than 0.05 was considered to be significant. All relevant P- values calculated in this study are listed in Table S3.
###end p 90
###begin title 91
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 54 61 54 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
Measurement of SFY114 and SFY115 Fitness In Vitro And In Vivo
###end title 91
###begin p 92
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 97 99 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 639 641 629 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Strains SFY114 and SFY115 were grown overnight in YEPD and diluted to a density of 5x106 cells ml-1. Equal volumes of each culture were mixed together and cultures were grown under constant agitation at 30degreesC for 24 h. Growth of SFY114, SFY115 and the co-culture was determined at 2 h, 4 h, 8 h and 24 h by measuring the absorbance at 540 nm and by plating diluted samples of the cultures onto YEPD agar plates. Since SFY115 is able to grow on high concentrations of fluconazole in contrast to SFY114, the relative proportion of both strains in the co-culture was determined by replicating colonies onto YEPD agar containing 30 microg-1 ml of fluconazole. After incubation at 30degreesC for 48 h, colonies on YEPD plates and on plates containing fluconazole were counted.
###end p 92
###begin p 93
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 624 626 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 201 205 <span type="species:ncbi:10090">mice</span>
###xml 366 370 <span type="species:ncbi:10090">mice</span>
For in vivo fitness assays, cultures of strains SFY114 and SFY115 were diluted to a density of 4x107 CFUs and these suspensions were used to infect three groups of mice (four per group). Two groups of mice were infected with SFY114 and SFY115, respectively, and the third group with both strains mixed at a ration of 1:1. At two, four and seven days post-infection, mice were sacrificed and kidneys homogenates were obtained (see above). Diluted samples from these homogenates were plated onto YEPD. Colonies grown after two days of incubation at 30degreesC were replicated onto YEPD plates containing fluconazole (30 microg-1 ml) to determine the relative proportion of both strains as above-described.
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin p 95
###xml 42 53 42 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 289 293 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000268-Sanglard3">[10]</xref>
###xml 42 53 <span type="species:ncbi:5478">C. glabrata</span>
###xml 206 212 <span type="species:ncbi:9986">rabbit</span>
Immunodetection of CgCdr1p and CgCdr2p in C. glabrata. Panel A: Sequential and related isolates. Panel B: Unrelated clinical isolates. Proteins extract were separated by SDS-10% PAGE and immunoblotted with rabbit polyclonal anti-CgCdr1p and anti-CgCdr2p antibodies as described previously [10]. MICs to fluconazole were determined by broth microdilution method in accordance with the CLSI M27-A2 document (National Committee for Clinical Laboratory Standards, 2002).
###end p 95
###begin p 96
(3.03 MB TIF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 68 79 68 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 399 410 399 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 601 612 601 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 740 741 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 750 752 744 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 68 79 <span type="species:ncbi:5478">C. glabrata</span>
###xml 399 410 <span type="species:ncbi:5478">C. glabrata</span>
###xml 601 612 <span type="species:ncbi:5478">C. glabrata</span>
Mitochondrial dysfunction in clinical isolates. Panel A: Ability of C. glabrata clinical isolates to grow on medium containing glucose (YEPD) or glycerol (YEPG) as carbon source. Azole-susceptible strains DSY2281, DSY2324 and BPY41 are respiratory competent while their matched azole-resistant isolates, DSY2282, DSY2325 and BPY41, respectively, show mitochondrial dysfunction. Panel B: Staining of C. glabrata mitochondrial DNA with the fluorescent dye SYTO18 and examined by either phase-contrast (Nomarsky) or fluorescence microscopy. Mitochondrial DNA was stained using SYTO18 (Molecular Probes). C. glabrata cells growing exponentially in YEPD at 30degreesC were harvested, suspended in 10 mM HEPES buffer pH 7.4 with 5% glucose, at 106 cells ml-1 and mixed with SYTO18 to a final concentration of 10 mM to stain at 25degreesC for 5 min. The stained cells were washed and suspended with 10 mM HEPES and observed under a fluorescence microscope.
###end p 98
###begin p 99
(1.47 MB TIF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 243 249 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 402 408 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 430 436 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgACT1</italic>
###xml 482 488 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 575 581 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 624 630 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 682 688 678 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000268-g003">Fig. 3</xref>
###xml 722 728 718 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 889 895 885 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Expression of CgPDR1 in matched pairs of clinical isolates (DSY), in revertant strains (rev) and in a pdr1Delta mutant (SFY92). RNA was isolated from log phase cultures, slot-blotted to membranes and hybridized with the indicated gene probes. CgACT1 served as internal control. Signals obtained in blotted membranes were quantified by counting radioactivity with phosphor imaging. Signals obtained for CgPDR1 were normalized with CgACT1. Expression values represent the increase of CgPDR1 expression in revertant strains relative to the clinical isolates expressing the same CgPDR1 allele. Since slot-blot quantification of CgPDR1 expression was comparable to real time RT-PCR (see Fig. 3), only slot-blot data are shown. CgPDR1 alleles present in each strain ("DSY" for clinical strains and "rev" for revertant strains) are named according to their strain numbers and to their associated CgPDR1 amino acid substitution (in superscript).
###end p 101
###begin p 102
(1.94 MB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 170 181 170 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 716 724 716 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
###xml 910 914 910 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 1032 1036 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pdr1</italic>
###xml 1145 1151 1137 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 1273 1274 1265 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1291 1302 1283 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 1414 1416 1406 1408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 20 26 <span type="species:ncbi:10090">murine</span>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 170 181 <span type="species:ncbi:5478">C. glabrata</span>
###xml 191 195 <span type="species:ncbi:10090">Mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 1236 1240 <span type="species:ncbi:10090">mice</span>
###xml 1291 1302 <span type="species:ncbi:5478">C. glabrata</span>
###xml 1319 1323 <span type="species:ncbi:10090">mice</span>
###xml 1498 1502 <span type="species:ncbi:10090">Mice</span>
###xml 1606 1610 <span type="species:ncbi:10090">mice</span>
###xml 1675 1679 <span type="species:ncbi:10090">mice</span>
Virulence assays in murine infection models. Panel A: Fungal tissue burdens in spleen from immuno-competent BALB/c mice infected intravenously with 4x107 viable cells of C. glabrata strains. Mice were sacrificed at day 7 post-infection and results, which are expressed as CFUs per gram of tissue, represent means of values recorded separately for each of the ten mice. Geometric means are indicated by horizontal bars and asterisks indicate statistically significant differences (*: P<0.05; **: P<0.01; ***: P<0.001). NS indicates no significance (P>0.05). Prism 5.0 was used for statistical analysis and data were processed with non-parametric Wilocoxon Rank sum tests. Comparisons are indicated in the Figure (see Table S3 for details) and associate selected data points. The origin of each strain is indicated. Strain background (DSY562 or DSY565) is indicated by filled or empty symbols, respectively. The pdr1Delta mutants from strains DSY562 and DSY565 correspond to SFY92 and SFY94, respectively. Revertants constructed from pdr1Delta mutants are indicated by the re-introduced gain of function mutation or by the re-introduced wild type CgPDR1 allele from DSY562. Panel B: Fungal tissue burdens in spleen from immuno-suppressed mice infected intravenously with 4x107 viable cells of C. glabrata strains. BALB/c mice were rendered neutropenic by intraperitoneal administration of cyclophosphamide (200 mg kg-1 of body weight per day) three days before challenge and on the day of infection. Mice were sacrificed at day 7 post-infection. Panel C: Fungal tissue burdens in liver from immuno-competent mice. Panel D: Fungal tissue burdens in liver from immuno-suppressed mice.
###end p 104
###begin p 105
(0.71 MB TIF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 31 42 31 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. glabrata</italic>
###xml 402 422 402 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material and Methods</xref>
###xml 566 567 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1179 1187 1179 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000268.s008">Table S3</xref>
###xml 31 42 <span type="species:ncbi:5478">C. glabrata</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 538 542 <span type="species:ncbi:10090">Mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
Efficacy of azole treatment in C. glabrata. Panel A: Fungal tissue burdens in spleen from untreated (filled symbols) and fluconazole-treated (open symbols) animals. Panel B: Fungal tissue burdens in liver from untreated (filled symbols) and fluconazole-treated (open symbols) animals. Fluconazole (100 mg/Kg/day) was administered by intra-peritoneal injection in immuno-suppressed mice as described in Material and Methods. Treatment was initiated 24 h after inoculation (day 1 post-infection) and continued through day 7 post-infection. Mice were injected with 4x107 CFU of each investigated strain and organ homogenates were obtained from ten mice per group that were sacrificed and necropsied on day 8 post-infection. Results, which are expressed as CFUs per gram of tissue, represent means of values recorded separately for each of the ten mice. Geometric means are indicated by horizontal bars and asterisks indicate statistically significant differences between two conditions (*: P<0.05; **: P<0.01; ***: P<0.001). NS indicates no significance (P>0.05). Prism 5.0 was used for statistical analysis and data were processed with non-parametric Wilocoxon Rank sum tests (see Table S3 for details).
###end p 107
###begin p 108
(0.63 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
Strains used in this study.
###end p 110
###begin p 111
(0.34 MB DOC)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
Position of mutations of all CgPDR1 alleles.
###end p 113
###begin p 114
(0.15 MB XLS)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
Details of statistical analysis.
###end p 116
###begin p 117
(0.27 MB DOC)
###end p 117
###begin p 118
Click here for additional data file.
###end p 118
###begin p 119
We thank J.P. Bouchara (Centre Hospitalier d'Angers, France), T. Yamazaki (Nippon Roche Research, Kanagawa, Japan), and M.E. Bougnoux (Necker Hospital, Paris, France) for providing strains used in this study. We thank Marilena La Sorda and Riccardo Torelli for their technical assistance in animal experiments. We thank Alix Coste, Philippe Hauser, and Libera Lo Presti for critical reading of the manuscript.
###end p 119
###begin title 120
References
###end title 120
###begin article-title 121
###xml 136 144 <span type="species:ncbi:9606">patients</span>
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
###end article-title 121
###begin article-title 122
Epidemiology of invasive candidiasis: a persistent public health problem.
###end article-title 122
###begin article-title 123
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
###xml 119 142 119 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 119 131 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 119 142 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.
###end article-title 123
###begin article-title 124
###xml 49 65 49 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 49 65 <span type="species:ncbi:5478">Candida glabrata</span>
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis.
###end article-title 124
###begin article-title 125
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.
###end article-title 125
###begin article-title 126
###xml 55 71 55 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 55 71 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.
###end article-title 126
###begin article-title 127
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
###end article-title 127
###begin article-title 128
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDH1</italic>
###xml 116 132 116 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 116 132 <span type="species:ncbi:5478">Candida glabrata</span>
Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.
###end article-title 128
###begin article-title 129
###xml 115 131 115 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 115 131 <span type="species:ncbi:5478">Candida glabrata</span>
Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
###end article-title 129
###begin article-title 130
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgCDR1</italic>
###xml 54 70 54 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 54 70 <span type="species:ncbi:5478">Candida glabrata</span>
The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
###end article-title 130
###begin article-title 131
###xml 20 36 20 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 20 36 <span type="species:ncbi:5478">Candida glabrata</span>
Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
###end article-title 131
###begin article-title 132
###xml 12 28 12 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDH1</italic>
###xml 12 28 <span type="species:ncbi:5478">Candida glabrata</span>
Function of Candida glabrata ABC transporter gene, PDH1.
###end article-title 132
###begin article-title 133
###xml 55 71 55 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 55 71 <span type="species:ncbi:5478">Candida glabrata</span>
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
###end article-title 133
###begin article-title 134
###xml 39 55 39 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 39 55 <span type="species:ncbi:5478">Candida glabrata</span>
Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
###end article-title 134
###begin article-title 135
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata PDR1</italic>
###xml 0 16 <span type="species:ncbi:5478">Candida glabrata</span>
Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
###end article-title 135
###begin article-title 136
A nuclear receptor-like pathway regulating multidrug resistance in fungi.
###end article-title 136
###begin article-title 137
###xml 51 57 51 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgSNQ2</italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CgPDR1</italic>
###xml 118 134 118 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 118 134 <span type="species:ncbi:5478">Candida glabrata</span>
The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
###end article-title 137
###begin article-title 138
###xml 57 73 57 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 57 73 <span type="species:ncbi:5478">Candida glabrata</span>
In-vivo selection of an azole-resistant petite mutant of Candida glabrata.
###end article-title 138
###begin article-title 139
###xml 15 31 15 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 15 31 <span type="species:ncbi:5478">Candida glabrata</span>
Isolation of a Candida glabrata centromere and its use in construction of plasmid vectors.
###end article-title 139
###begin article-title 140
###xml 55 71 55 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 55 71 <span type="species:ncbi:5478">Candida glabrata</span>
Caspofungin in combination with amphotericin B against Candida glabrata.
###end article-title 140
###begin article-title 141
###xml 96 112 96 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 96 112 <span type="species:ncbi:5478">Candida glabrata</span>
A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence of Candida glabrata.
###end article-title 141
###begin article-title 142
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE2</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SWI5</italic>
###xml 103 109 <span type="species:ncbi:4932">yeasts</span>
Different consequences of ACE2 and SWI5 gene disruptions for virulence of pathogenic and nonpathogenic yeasts.
###end article-title 142
###begin article-title 143
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR3</italic>
###xml 12 17 <span type="species:ncbi:4932">yeast</span>
PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon.
###end article-title 143
###begin article-title 144
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDR1</italic>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes.
###end article-title 144
###begin article-title 145
A fungal family of transcriptional regulators: the zinc cluster proteins.
###end article-title 145
###begin article-title 146
###xml 31 36 <span type="species:ncbi:4932">yeast</span>
Positive autoregulation of the yeast transcription factor Pdr3p, which is involved in control of drug resistance.
###end article-title 146
###begin article-title 147
###xml 25 41 25 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 25 41 <span type="species:ncbi:5478">Candida glabrata</span>
Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.
###end article-title 147
###begin article-title 148
Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.
###end article-title 148
###begin article-title 149
The biological cost of mutational antibiotic resistance: any practical conclusions?
###end article-title 149
###begin article-title 150
###xml 85 106 85 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria gonorrhoeae</italic>
###xml 85 106 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
Regulation of the MtrC-MtrD-MtrE efflux-pump system modulates the in vivo fitness of Neisseria gonorrhoeae.
###end article-title 150
###begin article-title 151
###xml 49 75 49 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 49 75 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
###end article-title 151
###begin article-title 152
###xml 19 35 19 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 19 35 <span type="species:ncbi:5476">Candida albicans</span>
Fluconazole versus Candida albicans: a complex relationship.
###end article-title 152
###begin article-title 153
###xml 86 102 86 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 86 102 <span type="species:ncbi:5476">Candida albicans</span>
Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans.
###end article-title 153
###begin article-title 154
###xml 43 59 43 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 104 107 104 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDR</italic>
###xml 43 59 <span type="species:ncbi:5476">Candida albicans</span>
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR.
###end article-title 154
###begin article-title 155
###xml 41 57 41 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 41 57 <span type="species:ncbi:5476">Candida albicans</span>
###xml 94 101 <span type="species:ncbi:9606">patient</span>
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation.
###end article-title 155
###begin article-title 156
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 159 170 159 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. albicans</italic>
###xml 61 77 <span type="species:ncbi:5476">Candida albicans</span>
###xml 159 170 <span type="species:ncbi:5476">C. albicans</span>
###xml 174 202 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 212 220 <span type="species:ncbi:9606">patients</span>
Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
###end article-title 156
###begin article-title 157
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida</italic>
In vivo pathogenicity of eight medically relevant Candida species in an animal model.
###end article-title 157
###begin article-title 158
###xml 56 72 56 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 77 93 77 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida albicans</italic>
###xml 56 72 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 77 93 <span type="species:ncbi:5476">Candida albicans</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
###end article-title 158
###begin article-title 159
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACE2</italic>
###xml 70 86 70 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 70 86 <span type="species:ncbi:5478">Candida glabrata</span>
Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence.
###end article-title 159
###begin article-title 160
###xml 78 101 78 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cryptococcus neoformans</italic>
###xml 78 90 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 78 101 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans.
###end article-title 160
###begin article-title 161
###xml 62 78 62 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Candida glabrata</italic>
###xml 62 78 <span type="species:ncbi:5478">Candida glabrata</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
###end article-title 161
###begin article-title 162
###xml 76 82 <span type="species:ncbi:10090">murine</span>
###xml 118 134 <span type="species:ncbi:5478">Candida glabrata</span>
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
###end article-title 162
###begin article-title 163
###xml 21 37 <span type="species:ncbi:5478">Candida glabrata</span>
Posaconazole against Candida glabrata isolates with various susceptibilities to fluconazole.
###end article-title 163
###begin article-title 164
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
###end article-title 164
###begin article-title 165
Drug resistance: the fight against fungi.
###end article-title 165
###begin article-title 166
###xml 55 60 <span type="species:ncbi:4932">yeast</span>
Multiple resistance mechanisms to azole antifungals in yeast clinical isolates.
###end article-title 166
###begin p 167
The authors have declared that no competing interests exist.
###end p 167
###begin p 168
This study was supported by a grant from the European community under the research program EURESFUN (LSHM-CT-2005-518199). M.S. was supported by a grant from the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Strategic Research Program 2006, Italy).
###end p 168

